The Fasa Registry on Systolic Heart Failure (FaRSH): Feasibility Study and the First 5-year Reports

  • Mohammad Hosein Yazdanpanah 1. Student Research Committee, Fasa University of Medical Sciences, Fasa, Iran 2. Non-communicable Diseases Research Center, Fasa University of Medical Sciences, Fasa, Iran http://orcid.org/0000-0003-3645-9430
  • Ehsan Bahramali 2. Non-communicable Diseases Research Center, Fasa University of Medical Sciences, Fasa, Iran 3. Digestive Disease Research Center, Digestive Disease Research Institute, Shariati Hospital, Tehran University of Medical Sciences, Tehran, Iran http://orcid.org/0000-0001-5398-9519
  • Maryam Kazemi 4. Department of Community and Preventive Medicine, Fasa University of Medical Sciences, Fasa, Iran 5. Health Policy Research Center, Institute of Health, Shiraz University of Medical Sciences, Shiraz, Iran
  • Negar Firouzabadi 6. Department of Pharmacology and Toxicology, School of Pharmacy, Shiraz University of Medical Sciences, Shiraz, Iran
  • Peyman Arasteh 2. Non-communicable Diseases Research Center, Fasa University of Medical Sciences, Fasa, Iran 7. Department of MPH, Shiraz University of Medical Sciences, Shiraz, Iran
  • Reza Homayounfar 2. Non-communicable Diseases Research Center, Fasa University of Medical Sciences, Fasa, Iran
  • Alireza Sepehri Shamloo 8. Department of Electrophysiology, Heart Center Leipzig at University of Leipzig, Germany
  • Mojtaba Farjam 2. Non-communicable Diseases Research Center, Fasa University of Medical Sciences, Fasa, Iran
Keywords: Heart Failure, Systolic, Registry, Iran

Abstract

Background: The literature on patients with heart failure (HF) from the Middle East, besides a few existing registries, is scarce. We report, for the first time in our country, a hospital-based registry for systolic HF. Materials and Methods: This was a web-based registry on HF, conducted in Vali-Asr Hospital affiliated with Fasa University of Medical Sciences, Fasa, Iran. The goal of this registry was to define overall baseline clinical characteristics and natural history of hospitalized patients with systolic HF, to evaluate current management schema and implementation of practice guidelines, and to determine the correlation between genetic predisposition environmental effects, individuals’ characteristics of health, lifestyle, morbidity, and mortality in relation with the effects of medication. Results: To date, 2378 individuals with a mean of age 67.08±13.07 years have been registered. Among which, 1381 (58.07%) patients were diagnosed with denovo HF. Most of the patients (60.1%) were male, and 8.9% had admissions during the past 30 days. The most common causes of HF were ischemic heart disease (86.5%) and hypertension (5.3%). Most patients had NYHA class one (44.3%) and three (20.4%). Overall, near 30% had diabetes and more than 38% had hyperlipidemia. Most individuals have been not a history of cigarette smoking (68.7%) or water-pipe smoking (96.9%). Also, 22.2% were current opium users, and 3.2% were previous opium users. Conclusions: The findings of this registry could make a realistic view of HF as a chronic disease with a burden. Therefore, policymakers can design programs and guidelines to prevent disease and better survival and quality of life. [GMJ.2021;10:e2111]  

References

Ambrosy AP, Fonarow GC, Butler J, Chioncel O, Greene SJ, Vaduganathan M, et al. The global health and economic burden of hospitalizations for heart failure: lessons learned from hospitalized heart failure registries. J Am Coll Cardiol. 2014;63(12):1123-33.

https://doi.org/10.1016/j.jacc.2013.11.053

PMid:24491689

Ponikowski P, Voors AA, Anker SD, Bueno H, Cleland JG, Coats AJ, et al. 2016 ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure: The Task Force for the diagnosis and treatment of acute and chronic heart failure of the European Society of Cardiology (ESC)Developed with the special contribution of the Heart Failure Association (HFA) of the ESC. Eur Heart J. 2016;37(27):2129-200.

https://doi.org/10.1093/eurheartj/ehw128

PMid:27206819

Adams KF, Jr., Fonarow GC, Emerman CL, LeJemtel TH, Costanzo MR, Abraham WT, et al. Characteristics and outcomes of patients hospitalized for heart failure in the United States: rationale, design, and preliminary observations from the first 100,000 cases in the Acute Decompensated Heart Failure National Registry (ADHERE). Am Heart J. 2005;149(2):209-16.

https://doi.org/10.1016/j.ahj.2004.08.005

PMid:15846257

Fonarow GC, Abraham WT, Albert NM, Gattis WA, Gheorghiade M, Greenberg B, et al. Organized Program to Initiate Lifesaving Treatment in Hospitalized Patients with Heart Failure (OPTIMIZE-HF): rationale and design. Am Heart J. 2004;148(1):43-51.

https://doi.org/10.1016/j.ahj.2004.03.004

PMid:15215791

Rajadurai J, Tse H-F, Wang C-H, Yang N-I, Zhou J, Sim D. Understanding the epidemiology of heart failure to improve management practices: an Asia-Pacific perspective. J Card Fail. 2017;23(4):327-9.

https://doi.org/10.1016/j.cardfail.2017.01.004

PMid:28111226

Djoussé L, Driver JA, Gaziano JM. Relation between modifiable lifestyle factors and lifetime risk of heart failure. JAMA. 2009;302(4):394-400.

https://doi.org/10.1001/jama.2009.1062

PMid:19622818 PMCid:PMC2742484

Okura Y, Ramadan MM, Ohno Y, Mitsuma W, Tanaka K, Ito M, et al. Impending epidemic: future projection of heart failure in Japan to the year 2055. Circ J. 2008;72(3):489-91.

https://doi.org/10.1253/circj.72.489

PMid:18296852

Bonneux L, Barendregt JJ, Meeter K, Bonsel GJ, van der Maas PJ. Estimating clinical morbidity due to ischemic heart disease and congestive heart failure: the future rise of heart failure. Am J Public Health. 1994;84(1):20-8.

https://doi.org/10.2105/AJPH.84.1.20

PMid:8279606 PMCid:PMC1614906

ICD - Classification of Diseases F, and Disability [Internet]. Atlanta (GA): National Center for Health Statistics; Available from: http://www.cdc.gov/nchs/icd.htm; International Classification of Diseases, Tenth Revision (ICD-10).

Bahramali E, Askari A, Zakeri H, Farjam M, Dehghan A, Zendehdel K. Fasa Registry on Acute Myocardial Infarction (FaRMI): Feasibility Study and Pilot Phase Results. PloS one. 2016;11(12):e0167579.

https://doi.org/10.1371/journal.pone.0167579

PMid:27907128 PMCid:PMC5132161

Pezeshki B, Karimi A, Ansari A, Yazdanpanah MH, Elmi M, Farjam M, et al. Fasa Registry on Diabetes Mellitus (FaRD): Feasibility Study and Pilot Phase Results. GMJ. 2021;10:e2137.

https://doi.org/10.31661/gmj.v10i0.2137

Naghavi M, Shahraz S, Sepanlou SG, Dicker D, Naghavi P, Pourmalek F, et al. Health transition in Iran toward chronic diseases based on results of Global Burden of Disease 2010. Arch Iran Med. 2014;17(5):321-35.

Yazdanpanah MH, Homayounfar R, Khademi A, Zarei F, Shahidi A, Farjam M. Short sleep is associated with higher prevalence and increased predicted risk of cardiovascular diseases in an Iranian population: Fasa PERSIAN Cohort Study. Sci Rep. 2020;10(1):1-13.

https://doi.org/10.1038/s41598-020-61506-0

PMid:32165672 PMCid:PMC7067883

Sato N, Kajimoto K, Asai K, Mizuno M, Minami Y, Nagashima M, et al. Acute decompensated heart failure syndromes (ATTEND) registry. A prospective observational multicenter cohort study: rationale, design, and preliminary data. Am Heart J. 2010;159(6):949-55.

https://doi.org/10.1016/j.ahj.2010.03.019

PMid:20569705

Lam CS, Teng T-HK, Tay WT, Anand I, Zhang S, Shimizu W, et al. Regional and ethnic differences among patients with heart failure in Asia: the Asian sudden cardiac death in heart failure registry. Eur Heart J. 2016;37(41):3141-53.

https://doi.org/10.1093/eurheartj/ehw331

PMid:27502121

Liu X, Yu H, Pei J, Chu J, Pu J, Zhang S. Clinical characteristics and long-term prognosis in patients with chronic heart failure and reduced ejection fraction in China. Heart Lung Circ. 2014;23(9):818-26.

https://doi.org/10.1016/j.hlc.2014.02.022

PMid:24881031

Yu SB, Cui HY, Qin M, Kong B, Liu T, Zhao QY, et al. [Characteristics of in-hospital patients with chronic heart failure in Hubei province from 2000 to 2010]. Zhonghua xin xue guan bing za zhi. 2011;39(6):549-52.

Mao C-T, Liu M-H, Hsu K-H, Fu T-C, Wang J-S, Huang Y-Y, et al. Effect of multidisciplinary disease management for hospitalized heart failure under a national health insurance programme. J Cardiovasc Med (Hagerstown). 2015;16(9):616-24.

https://doi.org/10.2459/JCM.0000000000000089

PMid:25105284

Wang C-C, Chang H-Y, Yin W-H, Wu Y-W, Chu P-H, Wu C-C, et al. TSOC-HFrEF Registry: A Registry of Hospitalized Patients with Decompensated Systolic Heart Failure: Description of Population and Management. Acta Cardiol Sin. 2016;32(4):400-11.

Youn YJ, Yoo B-S, Lee J-W, Kim J-Y, Han SW, Jeon E-S, et al. Treatment performance measures affect clinical outcomes in patients with acute systolic heart failure. Circ J. 2012;76(5):1151-8.

https://doi.org/10.1253/circj.CJ-11-1093

PMid:22343195

Zubaid M, Rashed WA, Al-Khaja N, Almahmeed W, Al-Lawati J, Sulaiman K, et al. Clinical presentation and outcomes of acute coronary syndromes in the gulf registry of acute coronary events (Gulf RACE). Saudi Med J. 2008;29(2):251-5.

Sulaiman KJ, Panduranga P, Al-Zakwani I, Alsheikh-Ali A, Al-Habib K, Al-Suwaidi J, et al. Rationale, Design, Methodology and Hospital Characteristics of the First Gulf Acute Heart Failure Registry (Gulf CARE). Heart views. 2014;15(1):6-12.

https://doi.org/10.4103/1995-705X.132137

PMid:24949181 PMCid:PMC4062990

AlHabib KF, Elasfar AA, AlBackr H, AlFaleh H, Hersi A, AlShaer F et al. Design and preliminary results of the heart function assessment registry trial in Saudi Arabia (HEARTS) in patients with acute and chronic heart failure. Eur J Heart Fail. 2011;13(11):1178-84.

https://doi.org/10.1093/eurjhf/hfr111

PMid:21873337

Nieminen MS, Brutsaert D, Dickstein K, Drexler H, Follath F, Harjola V-P, et al. EuroHeart Failure Survey II (EHFS II): a survey on hospitalized acute heart failure patients: description of population. Eur Heart J. 2006;27(22):2725-36.

https://doi.org/10.1093/eurheartj/ehl193

PMid:17000631

Jonsson Å, Edner M, Alehagen U, Dahlström U. Heart failure registry: a valuable tool for improving the management of patients with heart failure. Eur J Heart Fail. 2010;12(1):25-31.

https://doi.org/10.1093/eurjhf/hfp175

PMid:20023041

Yancy CW, Fonarow GC. Quality of care and outcomes in acute decompensated heart failure: The ADHERE Registry. Curr Heart Fail Rep. 2004;1(3):121-8.

https://doi.org/10.1007/s11897-004-0021-8

PMid:16036035

Sulaiman K, Panduranga P, Al-Zakwani I, Alsheikh-Ali AA, AlHabib KF, Al-Suwaidi J et al. Clinical characteristics, management, and outcomes of acute heart failure patients: observations from the Gulf acute heart failure registry (Gulf CARE). Eur J Heart Fail. 2015;17(4):374-84.

https://doi.org/10.1002/ejhf.245

PMid:25739882

AlHabib KF, Elasfar AA, AlBackr H, AlFaleh H, Hersi A, AlShaer F, et al. Design and preliminary results of the heart function assessment registry trial in Saudi Arabia (HEARTS) in patients with acute and chronic heart failure. Eur J Heart Fail. 2011;13(11):1178-84.

https://doi.org/10.1093/eurjhf/hfr111

PMid:21873337

Yazdanpanah MH, Sayyadipoor S, Hojati SR, Nikmanesh A, Farjam M, Homayounfar R. The Association of Metabolic Syndrome and Its Components with Electrocardiogram Parameters and Abnormalities Among an Iranian Rural Population: The Fasa PERSIAN Cohort Study. Diabetes Metab Syndr Obes. 2020;13:2975.

https://doi.org/10.2147/DMSO.S263093

PMid:32943893 PMCid:PMC7467662

Yazdanpanah MH, Bahramali E, Naghizadeh MM, Farjam M, Mobasheri M, Dadvand S. Different body parts' fat mass and corrected QT interval on the electrocardiogram: The Fasa PERSIAN Cohort Study. BMC Cardiovasc Disord. 2021;21(1):1-11.

https://doi.org/10.1186/s12872-021-02095-2

PMid:34090333 PMCid:PMC8178852

Schultz JE, Gross GJ. Opioids and cardioprotection. Pharmacol Ther. 2001;89(2):123-37.

https://doi.org/10.1016/S0163-7258(00)00106-6

Misra P, Caldito GC, Kakkar AK, Mancini MC, Reddy PC. Outcomes of coronary artery bypass grafting in patients with a history of illicit drug use. Am J Cardiol. 2003;92(5):593-5.

https://doi.org/10.1016/S0002-9149(03)00730-6

Aghadavoudi O, Eizadi-Mood N, Najarzadegan MR. Comparing cardiovascular factors in opium abusers and non-users candidate for coronary artery bypass graft surgery. Adv Biomed Res. 2015;4:12.

https://doi.org/10.4103/2277-9175.148294

PMid:25625118 PMCid:PMC4300596

Sulaiman K, Panduranga P, Al‐Zakwani I, Alsheikh‐Ali AA, AlHabib KF, Al‐Suwaidi J, et al. Clinical characteristics, management, and outcomes of acute heart failure patients: observations from the Gulf acute heart failure registry (Gulf CARE). Eur J Heart Fail. 2015;17(4):374-84.

https://doi.org/10.1002/ejhf.245

PMid:25739882

Published
2021-12-14
How to Cite
Yazdanpanah, M. H., Bahramali, E., Kazemi, M., Firouzabadi, N., Arasteh, P., Homayounfar, R., Sepehri Shamloo, A., & Farjam, M. (2021). The Fasa Registry on Systolic Heart Failure (FaRSH): Feasibility Study and the First 5-year Reports. Galen Medical Journal, 10, e2111. Retrieved from https://gmj.ir/index.php/gmj/article/view/2111